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To obtain anamnestic antibody synthesis to a second antigenic stimulus the 
second antigen must share some immunogenic determinant with the primary 
sensitizing material.  Generally the secondary response takes place only to the 
common determinants (1-3). Occasional animals have been reported to undergo 
a  secondary antibody response to antigenic determinants specific only to the 
first antigen when injected with a cross-reacting antigen as the secondary stimu- 
lus  (1, 4). While the antibodies produced appeared to be specific for the first 
antigen based  on absorption of the secondary sera with  the second antigen, 
the  complexity of the  antigens  (albumins)  has  limited  the  interpretation  of 
these results. Albumins are multispecific antigens (5, 6) and the extent to which 
hidden determinants  of  one  species  might cross-react with  surface  determi- 
nants on a  cross-reacting species has not been investigated. 
An artificial haptenic group can represent a  significant portion of a  specific 
determinant.  Subtle alterations in the spacial configuration of haptens cause 
corresponding alterations  in  the  elicited  antihapten  antibodies  and  are  dis- 
tinguishable by them (7). However, in the past most experiments designed to 
induce a  specific anamnestic  antihapten  circulating antibody response inde- 
pendent of the cartier molecules have been unsuccessful (8-12). An exception 
was an experiment by Gold and Benedict (13) in which small increases in anti- 
p-aminobenzoic acid antibody levels were detected by hemagglutination fol- 
lowing administration of uncoupled hapten. The more common negative result 
led to the general conclusion expressed by Ovary and Benacerraf (10) that the 
antihapten-anamnestic  response  is  controlled in part by the "immunological 
backbone" of the cartier and that for this reason the original carrier is required 
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to stimulate a  secondary antihapten response. Recently, however, several re- 
ports indicated that this need not be the case and that it is possible for an un- 
related cartier protein to serve as a  secondary hapten carrier and that such a 
combination can induce an anamnestic antihapten response which in most but 
not all cases was of limited intensity (14-18). 
The purpose of this paper is to describe fully experiments presented in a pre- 
liminary report  (15)  concerning the anamnestic production of anti-TNP (tri- 
nitrophenyl)  precipitins  in  rabbits  primed  with  trinitrophenyl-hemocyanin 
(TNP-KLH) and recalled with TNP-bovine plasma albumin (TNP-BSA) or 
TNP-bovine gamma globulin (TNP-BGG)  at  intervals of  up  to  11  months 
after priming. The resultant antihapten responses were equal in magnitude to 
those recalled by the TNP-homologons carrier conjugate and independent of 
the measurable response to sensitization. 
Materials  and Methods 
Prot~ins.--Hemocyanin (KLH) was obtained from the keyhole limpet Megalhura cranulala 
by the method of Campbell et al. (19). Crystalline bovine plasma albumin (BSA) and bovine 
gamma globulin (BGG) were purchased from Armour Pharmaceutical  Company, Kankakee, 
Ill. Rabbit serum albumin (RSA) was precipitated by acetic acid from pooled normal rabbit 
serum after removal of the globulins by precipitation with half-saturated ammonium sulfate. 
Precipitated  albumin was dissolved and dialyzed against distilled water and concentrated 
by lyophiliTation. The protein was purified by preparative  starch block electrophoresis (19). 
The material was dialyzed free of salt with distilled water, clarified by low speed centrifuga- 
tion, and lyophilized. It was judged pure by immunoelectrophoresis. 
Preparation of Conjugates.--TNP-KLH was prepared as described previously (20). Mole 
ratios of TNP to K_LH ranged from TNP6~0KLH to TNPI~KLH as indicated in the text. 
TNP-BSA was prepared as in reference 20 except that the coupling reaction between BSA 
and trinitrobenzene sulfonic acid (TNBS), the reactive form of the hapten~ was stopped by 
the addition of 10 moles of glycylglycine per mole of hapten in the reaction mixture  (21). 
The conjugated protein was precipitated by the addition of cold 1 ~  acetic acid and centri- 
fuged. Borate buffer pH 8.6 (19) dissolved the precipitated  conjugate. After centrifugation 
the clarified protein  was passed through a  Sephadex G-50 column equilibrated in borate- 
saline (19) to remove free TNBS and TNP-glycylglycine. The cycle of precipitation and gel 
filtration was repeated once or twice more until the optical density ratio at 350 m/~/280 m/~ 
of the conjugate in borate-saline was the same after two successive column passages. Mole 
ratios of TNP to BSA prepared in this manner ranged from TNPItBSA to TNPt4BSA. 
TNP-RSA was prepared  similarly except that the coupling reaction was carried out in 
borate buffer pH 8.1 for 4 hr. The mole ratio of TNP to RSA was TNP~/70,000 tool wt RSA. 
TNP-BGG was prepared by reacting 0.19 g TNBS with 0.75 g BGG in 15 ml 0.1 M  phos- 
phate buffer pH 7.9 at 30°C in the dark. The reaction was stopped by addition of glycyl- 
giycine as above. During coupling the protein precipitated. It was collected by centrlfugation 
and dissolved by bringing the pH to 7.9 with 0.5 ~ NaOH. The conjugate was passed through 
Sephadex G-50 equilibrated in 0.1 M  phosphate-buffered saline pH 7.9. The conjugated pro- 
tein again precipitated on standing  in the cold and was used as a suspension for injection. There 
were approximately 13 moles of TNP/1.6 X  105 tool wt BGG. 
In order to eliminate the possibility of contamination of one protein preparation by another 
a new Sephadex gel was used for each procedure. A single gel was never used for more than a 
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Spectrophotometric determinations of hapten per protein were performed as in reference 
20. 
e-mono-TNP-T.-lysine was synthesized by a modification of Okuyama and Satake's method 
(22) using 2.4 g of T.-lysine:HC1 and 9.6 g of picryl chloride (1 chloro, 2, 4, 6 trinitrobenzene) 
obtained from Matheson, Coleman and Bell (Cincinnati, Ohio). After washing with benzene 
the product solution was adjusted to pH 3 with 6 ~ NaOH and the resulting precipitate dis- 
carded. The solution was adjusted to pH 6 with 1 N NaOH and allowed to stand for several 
hours in the cold whereupon the product crystallized. RecrystaUization was repeated twice 
at pH 6. The final product crystallized at pH 3. It was washed with absolute ethanol and 
ether and dried over PsOs, mp 198-199°C. Elemental analysis,  1 calculated for the hydrochlo- 
ride C, 35.00; H, 4.41; N, 17.01; C1, 8.61; O, 35.00. Found C, 35.59; H, 4.46; N, 17.47; Cl, 
8.61; O, 35.24. 
Ant~ser~.--Adult, male, New Zealand rabbits were used. All injections were intravenous 
without adjuvants. Antigen concentrations used for injection ranged from 10 to 15 mg pro- 
tein per milliliter saline. The total dose per injection was 15 mg protein per rabbit in all but 
the first experiment in which four rabbits received 25 nag protein each in the initial injection. 
Sensitization in all but one experiment consisted of two injections administered 18 days apart. 
The last experiment involved a single primary injection with no boosters prior to challenge. 
Animals  were bled from the ear at various intervals. Sera were stored in a freezer until tested. 
Qua~ita.li~e Pre~iiYitin  Ana/ys/s.--Duplicate tests were performed as described previously 
(20). Antibody to K.LH was determined using native KLH as precipitating antigen at pH 6.9. 
The first two experiments employed TNP-BSA as precipitating antigen for measuring anti- 
hapten antibody. Although control animals do not produce measurable amounts of anti- 
TN-P-BSA when given 15 mg of TNP-BSA the possibility exists that a small portion of the 
antibody labeled anti-TNP in Fig. 1 is actually coprecipitated anti-TNP-BSA. Subsequent 
experiments employed TNP-RSA as precipitating antigen for determining anti-TNP anti- 
body recalled with TNP-BSA. 
RESULTS 
Six rabbits were challenged 120 days after  the second of two sensitizing  in- 
jections  of TNP-KLH.  Three animals were challenged  with 15 mg TNP~  KLH 
and three with 15 mg TNP12BSA.  Two rabbits  in each group produced meas- 
urable amounts of anti-TNP  (Fig. 1). All six produced predpitins detectable 
by ring test.  Only the three rabbits challenged with TNP-KLH  showed an 
elevation  in anti-KLH titer.  In this  and in all  subsequent experiments prechal- 
lengc  injection  bleedings revealed low levels  of circulating  anti-K.LH precipitins 
persisting  in nearly all of the rabbits as a result  of previous exposure to TNP- 
KLH. This low level  was not measurable and is indicated by the points below 
I00 #g in Fig.  I.  Anti-TNP precipitins  were not detected in any rabbit at time 
of challenge.  The data indicate  an anamnestic antihapten response recalled  by 
the hapten-heterologous  carrier  complex because there  was no equivalent rise 
in anti-K_LH or anti-BSA (not shown) antibody and because control  rabbits  do 
not respond measurably to a single  intravenous injection  of TNP-BSA. 
All ring test-positive sera were tested for ability to flocculate by mixing equal 
volumes of serum and antigen and incubating at 37°C for 2  hr. Twofold dilu- 
z Elemental analysis performed by Elek  Microanalytical Laboratories, Torrance, Calif. 720  CARRIER-INDEPENDENT  ANTIHAPTEN  RESPONSE 
tiousof antigen from 160 #g N/ml to 2.5 #g N/ml were used (19). The statement 
that  certain sera did not contain measurable amounts  of antibody indicates 
that they did not flocculate in this preliminary test. None of the control animals 
used in this investigation produced measurable amounts of antibody after a 
single intravenous injection of either TNP-BSA or TNP-BGG. 
In a second experiment only 37 days elapsed between the second sensitizing 
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days after second sensitizing injection. Rabbits 5-92 and 5-94 were sensitized with 15 nag each 
and rabbits 6-05 and 6-10 with 25 mg each of TNP10mKLH.  Each of the four was reinjected 
18 days later with 15 nag of TNP~gKLH. The challenge injection consisted of 15 mg of either 
TNPeesKIX-I or TNPI~BSA as indicated in the figure. 
injection d  TNP-KLH  and challenge with  15  mg  TNP13BGG.  Four rabbits 
were so injected along with 10 normal control animals. While none of the con- 
trois showed antibody specific for the hapten, two of the four test rabbits did 
(Table I). A single control rabbit produced detectable precipitins to the heterol- 
ogous carrier protein BGG while three showed a response to the hapten-carrier 
complex TNP-BGG  (Table III). As  in  the first experiment there was no car- 
responding rise in anti-KLH titer (not shown). The two recall rabbits respond- 
ing to the hapten-heterologous carrier produced significant amounts  of anti- 
hapten antibody (Table II). Although there was no detectable antibody to BSA MARVIN  B.  RITTENBERG  AND  DAN  H.  CAMPBELL  721 
the possibility was entertained that a small portion of the antibody to TNP as 
measured by TNP-BSA was actually to the hapten-protein complex TNP-BSA 
as a result of the contamination by BSA of commercially prepared BGG. To 
test this possibility hapten inhibition by the method of Pauling, Pressman,  and 
Grossberg (23) was carried out on rabbit 7-59 7-day recall serum. ~-TNP-lysine 
was employed as inhibiting hapten with antigen and antibody at equivalence 
(Fig. 2). The shift in slope of the dashed line near complete inhibition suggests 
a  heterogeneity which  may reflect  antibody  directed  against  determinants 
TABLE  I 
Ring Tests on Sera from TNP-KLH-Sensitized  Rabbits* after Recall with TNP-Heterologous 
Carrier Conjugates 
Recall antigen 
TNP~aBGG 
TNPI~BSA 
Days to 
recall 
37 
77 
Day after 
recall 
7 
10 
14 
4 
7 
11 
T-BSA 
2/4§ 
2/4 
2/4 
115 
4/5 
5/5 
T-BGG 
3/4 
3/4 
3/4 
O/5 
3/5 
3/5 
Ring test antigen~ 
T-RSA  BSA 
0/4 
0/4 
0/4 
0/5 
3/5  2/5 
3/5  2/5 
BGG 
0/4 
0/4 
o/4 
RSA 
o/5 
o/5 
o/5 
* TNP-BGG group  sensitized with two  injections of  15 nag TNP61aKLH  administered 
18 days apart. TNP-BSA group sensitized as above with TNPTsoKLH.  Recall injections 15 
mg each. 
:~ Antigen concentrations for ring tests 10 #g N/ml. 
§ No. positive/No, tested. The lowest concentration of anti-TNP detectable by ring test 
was 25/zg/ml as determined with dilutions of antisera of known antibody content. 
other than the hapten-lysine, perhaps TNP-N-terminal amino acid or hapten- 
BSA complex. TNP-lysine did not inhibit precipitation of BSA-rabbit anti-BSA 
(not shown). 
A similar  experiment  was  carried  out after 77  days had elapsed  between 
sensitization  and heterologous recall with TNP-BSA. No response was seen in 
the control group until the 11th day after injection when precipitins  to TNP- 
BSA were detected in two rabbits. In contrast all five test animals showed anti- 
bodies to the recall antigen and in three of these there was antibody specific for 
the hapten as shown by reactivity wth TNP-RSA and TNP-BGG (Table  I). 
The sera of the heterologously recalled rabbits contained 0.5-1.2 mg anti-TNP 
by the 7th day after recall (Table  II). As in other experiments  there were no 
detectable anti-TNP precipitins  in these  rabbits just prior to challenge  and 
there was no increase in anti-KLH after challenge. The specificity of the anti- 
TNP produced  by rabbits 8-05 and 8-14 7 days after challenge was tested by 722  CARRIER-INDEPENDENT  ANTIHAPTEN  RESPONSE 
precipitation  inhibition  by  ~-TNP-lysine  at  antigen-antibody  equivalence 
(Fig.  2). The heterogeneity reflected by the slope of hapten inhibition in the 
TNP-BGG recall serum (dashed line) is absent in these sera. This result tends 
to reinforce the interpretation that a small portion of the apparent anti-TNP 
recalled by TNP-BGG as  tested for with  TNP-BSA  actually  was  directed 
toward some determinant other than TNP-lysine. Specificity of the  recaned 
antibody as measured by TNP-RSA is dearly antihapten. 
Two additional experiments of this type were performed. The interval be- 
tween  sensitization  and  challenge was  3  months  in  one  experiment and  11 
months in the second. One of the groups received one sensitizing injection rather 
than two. The response to sensitizing injections was evaluated quantitatively 
TABLE II 
Antihapten  Precipitin  Titers in Sera of TNP-KLH-Sensitized* Rabbits aft~ Challenge with 
TNP-Heterologous Carrier Conjugates 
Recall antigen 
TNPI3BGG 
TNPld3SA 
Days to recall 
37 
77 
Rabbit No. 
7-59 
7-62 
8-05 
8-10 
8-14 
~Micrograms anti-TNP/ml serum 
Day 7  Day 10-11 
675  519 
200  169 
513  4O0 
1275  675 
500  419 
* As in Table I. 
Quantitative precipitin taters. TNP-BSA was precipitant for TNP-BGG-recalled sera. 
TNP-RSA was precipitant for TNP-BSA-recaUed  sera. 
in order to see whether primary responsiveness to hapten had any effect on 
subsequent ability to respond to heterologous recall (Table IV). 
Reducing  to  one-half the  total antigen  administered  at  sensitization  and 
limiting  it  to a  single  primary injection did  not  affect recall of antihapten 
adversely. Extending the time between sensitization and challenge to 11 months 
did not affect the outcome adversely either. Whether or not a rabbit responded 
well to TNP after sensitization with TNP-KLH had no bearing on its response 
to challenge with TNP-BSA. Rabbits 8-36,  8-60,  and 8-61 responded poorly if 
at  all  to sensitization yet were good anti-TNP  producers on recall.  On  the 
contrary, rabbits 8-37,  8-39,  and 8-43  responded well to sensitization  but re- 
sponded minimally or not at all to recall. 
The responses of normal animals injected with the same TNP-BSA prepara- 
tions  used  in  the  above experiments were minimal  and  not  measurable  by 
quantitative precipitation (Table III). None of the rabbits showed any reactiv- MARVIN  B.  RITTENBERG  AND  DAN  H.  CAMPBELL  723 
ity with TNP-RSA and only 6/16 showed reactivity with the sensitizing anti- 
gen TNP-BSA as detected on the 10th or llth day. 
DISCUSSION 
These results demonstrate an anamnestic anfihapten precipitin response to 
hapten conjugated to a  heterologous carrier. The amount of antihapten  anti- 
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FIG. 2. Hapten inhibition of precipitation of recalled anti-TNP sera. Inhibition by e-mono- 
TNP-L-lysine. 0-4}, rabbit 7-59 challenged with 15 mg TNP-BGG 37 days after sensitiza- 
tion. Anti-TNP precipitated with TNP-BSA. O  O, rabbit 8-05, and •  •, rabbit 8-14 
challenged with  15 mg TNP-BSA 77 days after sensitization. Anfi-TNP precipitated with 
TN-P-RSA. 
Antisera were obtained 7 days after challenge. Inhibition was performed with antigen and 
antibody at equivalence. 
Hapten  similarly added to rabbit anti-BSA-BSA mixtures did not inhibit precipitation 
(not shown). 
body so produced is comparable with that induced by the hapten-homologous 
carrier  conjugate  as  described  previously  (20)  and  as  shown  here  (Fig.  1). 
Absence  of cross-reaction between  KLH and  BSA  as judged  by failure of 
these  proteins  to  cross-stimulate  in  vivo  immunological  processes  has  been 
shown (24,  25). During this investigation additional tests were made between 724  CARRIER-INDEPENDENT  ANTIHAPTEN  RESPONSE 
high titered anti-KLH or anti-BSA sera and the haptenated heterologous pro- 
teins. As tested by passive cutaneous anaphylaxis and gel diffusion there was no 
cross-reaction.  Nor was  there  an  increase  in  anti-KLH  titer  after  recall  with 
either TNP-BSA or TNP-BGG. 
Carrier  alone  was  not  able  to  recall  the  antihapten  response.  17  rabbits 
primed with TNP-KLH were challenged with KLH between 105 and 126 days 
after  sensitization.  All  failed  to  produce  detectable  antihapten  antibodies. 
TABLE III 
Responses of Normal  Unsensitized Rabbits to Recall Doses of TNP-Haerologous 
Carrier Conjugates 
Antigen* 
TNPIsBGG 
TNP-BSA[I 
Day a#er 
in3eetlon  T-BSA 
7  O/lO§ 
'  lO  O/lO 
14  0/10 
4  0/11 
7  0/16 
lO-ll  6/16 
14  4/11 
Ring test antigen:~ 
T-BGG 
3/10 
3/10 
3/10 
0/11 
0/11 
0/11 
0/6 
T-RSA 
o/11 
o/16 
o/16 
o/11 
BSA 
O/lO 
O/lO 
O/lO 
o/11 
o/16 
1/16 
o/11 
RSA 
o/11 
o/11 
o/11 
0/6 
BGG 
1/1o 
1/lO 
1/lO 
* Single intravenous  injection,  15 mg/rabbit. 
;~ As in Table I. 
§ As in Table I. 
I] Three different  preparations  were used,  conforming to those  used  as recall antigens. 
TNPI,BSA and TNPlxBSA each administered  to five control animals.  TNP~BSA admin- 
istered to six control animals. 
Although  early  experiments  (26-28)  indicated  that  immunologic recognition  of 
antigenic regions of haptenated proteins included more of the carrier in delayed than 
in immediate  hypersensitivity,  recent experiments  (29-32)  have narrowed this  dis- 
tinction. Leskowitz et al. (30) showed that delayed but not immediate hypersensitivity 
reactions were elicited  with arsanilate-protein in animals sensitized with arsanilate-N- 
acetyl-tyrosine indicating that a very small structural region can sensitize to delayed 
hypersensitivity. Schlossman and Levine (32) suggested that the size of the structural 
area  surrounding  the  hapten  as  measured  by delayed hypersensitivity  reflects  the 
functional region of hapten immunogenicity based on the ability of a-dinitrophenyl- 
hepta-L-lysine  to  both  immunize  and  to  elicit  delayed  hypersensitivity,  functions 
which the hexapeptide lacked. Presumably the size of the region would vary with the 
materials employed. Whether the ultimate size of such an immunogenic region would 
ever be so narrow as to encompass the hapten alone is not yet dear. This is suggested, 
however, by the successful elicitation of delayed hypersensitivity by arsanilate-salmine 
in animals sensitized to arsanilate-polytyrosine (29).  Salmine contains no tyrosine in- MARVIN  B,  RITTENBERG  AND  DAN  H.  CAMPBELL  725 
dicating that the immunogenic  haptenic determinant did not include specifically  the 
associated amino acid. 
The  experiments  reported  here  show  that  immunologically  recognizable 
portions of the carrier "backbone" are not required in the homologous hapten- 
heterologous  carrier  recall  of  circulating  antihapten  antibody.  While  it  is 
possible that submolecular  regions of similarity occur in KLH and BSA and 
BGG these are beyond detection by present immunologic methods. Possibly 
the hapten singles out such submolecular regions. Unlike the chloride form of 
TNP, picryl chloride (which also attacks phenolic hydroxy and imidazole imino 
groups),  the sulfonic acid form of TNP  as used here conjugates  to primary 
amino groups selectively  (22). Haptenation by this method results  in a more 
uniform product in which lysine accounts for nearly all of the conjugated amino 
acids except for the relatively small proportion of available N-terminal groups. 
While the immtmogenic region may be larger  than the hapten and adjacent 
amino acid or may include regions linearly distant due to spatial foldings of the 
carrier,  a certain degree of homogeneity is achieved by this haptenation pro- 
cedure. Whether reduced heterogeneity  in the site of hapten attachment affects 
success or failure of heterologous recall is not known. If submolecular environ- 
ment plays a  role in hapten immunogenicity, multiple environments on the 
sensitizing carrier  could provide  a better chance for finding some homologous 
environments when hapten is attached to other proteins. From a selective point 
of view, however, homogeneity of hapten attachment would result presumably 
in a reduced spectrum of cells responding to sensitization. In this sense prolifera- 
tion of a narrower class of antihapten-specific  cells might help to magnify the 
recall response when the hapten is presented on a carrier providing the proper 
environment. It should be noted that thus far attempts to recall  anti-TNP 
with mono-TNP-bovine-insul~n have failed.  2 In this case insulin provided a very 
homogeneous  environment with but a  single lysine located  on the B  chain 
accounting for approximately 95 % of the hapten. The remaining  hapten was 
found on the N-terminal amino acids glycine and phenylalanine. Since insulin 
is a weak immunogen the reason for failure cannot be attributed directly to the 
hapten-carrier structural  relationship.  Other proteins  or  peptides  of known 
structure and greater ~mmunogenicity may offer a better means of testing this 
aspect of heterologous recall. 
While all of the animals responded  to heterologous  recall when challenged 
11 months after sensitization  it was possible also to obtain significant  recall 
after only 37 days had elapsed between sensitization  and challenge. Although 
the groups  were small  the proportion of positive  responders  (approximately 
50 %) was the same at challenge intervals lying between 37 days and 11 months. 
Therefore, while a very lengthy interval may enhance the ability of some ani- 
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mals to respond it is not an absolute requirement as was suggested by similar 
experiments  employing pneumococcus  and  pneumococcal polysaccharide  as 
sensitizing immunogen and challenging hapten respectively (18). These varia- 
tions in  time of successful recall may reflect differences in  the fundamental 
immunogenicities of the materials  employed as well as  differences in  size of 
individual cell populations capable of responding to a particular stimulus. They 
TABLE IV 
Comparison of Response to Sensitization  by  TNP-KLH  and Subsequent Ability to Respond 
to Haerologous Recall by TNP-BSA 
Rabbit 
No. 
8-36 
8-37 
8-38 
8-39 
8-42 
8-43 
8-57 
8-58 
8-59 
8-60 
8-61 
Sensitizing injections 
15 mg 
Ts~KLH 
15 mg 
Tlo~KLH 
15 mg 
TgeoKLH 
None 
4 
o! 
294 
294 
481 
Microgram anti-TNP*/ml serum 
Da~¢ after last 
sensittzing injection 
I 
o  0121 I 
556] 
~251I  I  ] 
275 
z7511  1  / 
t63  ] 
o  1so  1115  1so  I 
0269  244  306 
+  +1144  119  I 
0  +[+  131  / 
o I  o10 
Da~r after recall 
injection  }ays to 
'ecallt 
6-8  10  14. 
444  306[ 219 
O]  O~  0 
92  17~  +1471 ++ 
638111 6~  531 
o  + 
806 j 606  456 
i  188  131 
333  225  147  + 
225  394  300 
394  256  + 
I 
* Anti-TNP as measured by quantitative precipitation using TNP-BSA as precipitant 
before recall; TNP-RSA as precipitant after recall. 
8-36 through 8-43 recalled with  15 mg TNP13BSA. 8-57 through 8-61 recalled with 
TNPnBSA. 
§ 0, antibody not detectable by ring test. +, antibody detectable by ring test but amount 
insufficient to measure (see  text). 
]I Antibody values after absorption of complement and nonspecific  factors by treatment 
with washed heterologous  antigen-antibody complexes (20). 
may also reflect the suppressive effects of residual antihapten antibody (33). 
Although  these experiments were carried out after anti-TNP precipitins had 
disappeared, ring testing is too insensitive a method to insure that all animals 
had the same residual level of circulating anti-TNP at the time of recall. 
These studies were undertaken initially because TNP-KLH had proved to be 
a  potent immunogen which does not require adjuvant in order to elicit early 
precipitating antihapten  antibody (20).  It was felt that previous failures to 
demonstrate anamnestic antihapten responses independent of the carrier (8-12) MARVIN  B. RITTENBERG AND  DAN  H. CAMPBELL  727 
may have been due to weaker immunogenic  stimuli and that TNP-KLH could 
overcome this  deficiency.  The  data in Table IV which show no correlation 
between anti-TNP  response  after primary sensitization  and subsequent abil- 
ity  to  be  challenged  successfully  by  TNP-heterologous  carrier  conjugate 
indicate  that  potent  immunogenicity  of  primary  sensitization  does  not 
guarantee successful  recall.  Perhaps circulating  antibody levels do not reflect 
the extent of sensitization.  Although antihapten titer presumably parallels the 
size of the cell population producing specific antihapten antibody, the correla- 
tion may be too gross to provide a satisfactory index of sensitization,  particu- 
larly if only certain subpopulations of cells producing antihapten antibody will 
respond when the challenging  hapten is on a heterologous carrier.  If the latter 
were  the  case however,  the  heterologously recalled  response  would  not  be 
expected to equal the homologous response quantitatively yet it did in many 
animals.  The response of some cells to sensitization may be proliferative but 
nonantibody producing until a second antigenic contact occurs. Whereas others 
may respond directly to sensitization and produce antibody or continue pro- 
liferation to a  stage where they respond to persisting primary antigen  (34). 
These  experiments  differed from  others  mainly  in  the  use  of  a  primary 
immunogen,  TNP-KLH, which did not require adjuvant  to elicit a  primary 
antihapten  response.  Elimination  of adjuvants  made  possible recall  experi- 
ments at a time when antihapten antibodies were no longer detectable. In the 
other  reported successful experiment  in  which  recall  responses  were  deter- 
mined quantitatively antihapten  fiters only increased to twice the prerecall 
level and adjuvant was used during sensitization (18). Suppression by persisting 
antihapten antibody could have been the reason for failure or low level responses 
in that experiment although it did not suppress control animals injected with 
homologous conjugates. Presumably if persisting antibody were suppressing, 
then the greater the response to sensitization the greater would be the chance 
for  suppression;  the  frequency  of  successful  heterologous  recall  should  be 
inversely proportional to primary response. The data in Table IV do not allow 
such a conclusion.  There is no distinct correlation in either direction. 
These experiments show that large immunologically identifiable regions  of 
the primary carrier  molecule are not required  to elicit a  sizeable  secondary 
antihapten precipitin response.  Immunologically unrelated proteins may serve 
as hapten carriers for heterologous recall  of antihapten.  The extent to which 
regions  of  submolecular  homology between  primary  and  secondary  carrier 
contribute to antihapten recall remains to be determined. 
SlYMM.ARY 
Anamnestic  antihapten  responses were  obtained  to  trinitrophenyl  (TNP) 
when  rabbits  sensitized  to  trinitrophenyl-hemocyanin  (TNP-KLH)  were 
challenged  with TNP-heterologous protein  conjugates.  Hapten-heterologous 728  CARRIER-INDEPENDENT  ANTIH.APTEN  RESPONSE 
carrier  conjugates  elicited  antihapten  titers  similar  in  magnitude  to  those 
elicited  by  the  homologous  carrier  conjugate.  Hapten-heterologous  carrier 
recall of antihapten was successful as early as 37 days and as late as 11 months 
after sensitization.  There was no correlation between anti-TNP-precipitating 
antibody  titer  after sensitization  and  the  ability  to respond  to  challenge  by 
hapten-heterologous  carrier.  The  results  are  discussed  in  terms  of immuno- 
genicity of sensitization, suppressive effects of persisting postsensitization anti- 
body, and submolecular haptenic environment as factors possibly affecting the 
heterologous recall process. 
The authors gratefully acknowledge the excellent assistance of Mr. Bror Clark, Mr. Urs 
Rutishanser, Miss Jan Williams, and Miss Katherine Pratt. We wish to thank Dr. A. MaUey 
and Dr. A. A. Amkraut for critically reading this manuscript, and Dr. G. Strejan for helpful 
discussions during the course of the investigation. 
BIBLIOGRAPHY 
1.  Dixon, F. J., and P.  H. Maurer.  1955. Specificity  of the secondary response to 
protein antigens, ft. Immunol. 74:418. 
2.  Abramoff, P., and H. R. Wolfe. 1959. Specificity of anamnestic response in chick- 
ens. Proc. Soc. Exptl. Biol.  Med. 101:391. 
3.  Gilden,  R. V., and S. Tokuda.  1963. Antibody quality after sequential immuni- 
zation with related antigens. Science. 140:405. 
4.  Gilden,  R.  V.  1963. Antibody  responses  after  successive  injections  of  related 
antigens. Immunology.  6:30. 
5.  Lapresle, C., M. Kaminski, and C. E. Tanner.  1959. Immunochemical study of 
the enzymatic degradation of human serum albumin: An analysis of the anti- 
genic structure of a protein molecule. J. Immunol. 82:94. 
6.  Ishizaka, T., D. H.  Campbell, and K. Ishizaka. 1959. Internal antigenic deter- 
minants in protein molecules. Proc. Soc. Expll. Biol.  Med. 103:5. 
7.  Landsteiner, K.  1962. The Specificity  of Serological  Reactions. Dover Publica- 
tions,  Inc., New York. Revised edition. 
8.  Salvin,  S. B., and R. F. Smith. 1960. Specificity of allergic reactions. II. Azopro- 
teins in the anamnesfic response.  Proc. Soc. Exptl. Biol. Med. 104:584. 
9.  Salvln,  S. B., and R. F. Smith. 1960. The specificity  of allergic reactions. I. De- 
layed versus Arthus hypersensitivity. J. Exptl. Med. 111:465. 
10.  Ovary, Z., and B. Benacerraf.  1963. Immunological specificity  of the secondary 
response with dinitrophenylated proteins. Proc. Soc. Expa. Biol.  Med. 114:72. 
11.  Amkrant, A. A. 1963. Induction and properties of anti-hapten antibody. Doctoral 
Dissertation. Stanford University. p. 91. 
12.  Dutton, R. W., and H. N. Bulman. 1964. The significance of the protein carrier 
in the stimulation of DNA synthesis by hapten-protein conjugates in the sec- 
ondary response. Immunology.  7:54. 
13.  Gold,  E.  F.,  and A.  A.  Benedict.  1962. Formation of antibody to haptens.  1. 
Primary and secondary responseg to p-amino benzoic  acid and bovine 3,-glob- 
ulin in chickens and rabbits. J. Immunol. 89:234. 
14.  Eisen,  H.  N.  1966. The immune  response  to  a  simple antigenic  determinant. 
Harvey Lectures, 1964--1965.60:1. MARVIN  B.  RITTENBERG  AND  DAN  H.  CAMPBELL  729 
15.  Rittenberg, M. B. 1966. Ananmestic anti-hapten response induced with hapten- 
heterologous  protein conjugates. Federation Proc. 9.5:548. 
16.  Steiner,  L. A., and H. N. Eisen.  1966. Variations in the immune response to a 
simple determinant. B~teriol. Rev. 30:383. 
17.  Brownstone, A.,  N.  A. Mitchison,  and R. Pitt-Rivers.  1966. Biological  studies 
with an iodine-containing  synthetic immunological  determinant 4-hydroxy-3- 
IODO-5-nitrophenylacetic acid  (NIP)  and  related  compounds.  Immunology. 
10:481. 
18.  Paul, W. E., G. W. Siskind, B. Benacerraf., and Z. Ovary. 1967. Secondary anti- 
body responses  in haptenic systems: Cell population selection  by antigen. J. 
Immunol. 00:760. 
19.  Campbell, D. H., J. S. C~rvey, N. E. Cremer, and D. H. Sussdorf. 1963. Methods 
in Immunology. W. A. Benjamin, Inc., New York. 
20.  Rittenberg, M. B., and A. A. Amkrant. 1966. Immunogenicity of trinitrophenyl- 
hemocyanin:  Production  of primary and  secondary anti-hapten  precipitins. 
J. Immunol. 97:421. 
21.  Macris, N. T., and M. W. Chase.  1965. Further studies of dinitrophenylation and 
picrylation of proteins. Fe&ration Proc. 24:185. 
22.  Okuyama, T., and K. Satake. 1960. On the preparation and properties of 2,4,6- 
triultrophenyl-amino acids and-peptides. J. Biochem. 47:454. 
23.  Panling, L., D. Pressman, and A. Grossberg.  1944. Serological properties of simple 
substances: VII. Quantitative theory of inhlbition by lmptens of precipitation 
of heterogeneous  antisera with  antigens,  and  comparison with  experimental 
results for polyhaptenic simple substances and  for azoproteins. J. Am. Chem. 
Soc. 66:784. 
24.  Garvey, J. S., and D. H. Campbell. 1958. Effect of secondary injections of antigen 
upon the retention in the liver of a primary injection.  J. Exptl. Med. 10"/:497. 
25.  Garvey, J. S., and D. H. Campbell. 1959. The in vivo stability of antibody. J. 
Exptl. Med. 110:355. 
26.  Benacerraf, B., and P. G. H. Gell. 1959. Studies  on hypersensitivity. I. Delayed 
and arthus-type skin reactivity to protein conjugates in guinea pigs. Immu- 
nology. 2:53. 
27.  Benacerraf, B., and B. B. Levine. 1962. Immunological specificity of delayed and 
immediate hypersensitivity reactions.  J. Expg. M~. 11.5:1023. 
28.  Gell, P. G. H., and A. M. Silverstein.  1962. Delayed hypersensitivity to hapten- 
protein conjugates.  I. The effect of carrier protein and site of attachment to 
hapten. J. Exptl. Med. 115:1037. 
29.  Leskowitz, S. 1963. Immunochemical study of antigenic specificity in delayed hy- 
persensitivity. II. Delayed hypersensitivity to polytyrosine-azobenzenearsonate 
and its suppression  by haptens. J. Exptl. Med. 117:909. 
30.  Leskowitz,  S., V. E. Jones, and S. J. Zak. 1966. Immunochemical study of anti- 
genic specificity in delayed hypersensitivity. V. Immunization with monovalent 
low molecular weight conjugates.  J. Exptl. Me& 1~:229. 
31.  Schlossman,  S. F.,  S. Ben-Efraim, A. Yaron, and H. A. Sober.  1966. Immuno- 
chemical  studies on the antigenic determinants required to elicit  delayed and 
immediate hypersensitivity reactions.  J. Exptl. Med. 128:1083. 
32.  Schlossman, S. F., and It. Levine. 1967. Immunochemical studies on delayed and 730  CARRIER-INDEPENDENT  ANTIHAPTEI~  RESPONSE 
Arthus-type hypersensitivity reactions.  I. The relationship  between antigenic 
deteTminant  size and antibody combining site size. J. Immunol. 98:211. 
33.  Brodyl N. I., J. G. Walker,  and G. W. Siskind.  1967. Studies on the control of 
antibody synthesis.  Interaction of antigenic  competition and  suppression  of 
antibody formation by passive antibody on the immune response. J. Exptl. Med. 
126:81. 
34.  ~terzl, J., and A. M. Silverstein.  1967. Developmental aspects  of immunization. 
Adva~. Imm~nol. 6:337. 